Interestingly, we found that reduction of LDHC expression in the HLA-A*0201 positive cancer cells attenuated the T cell responses against LDHC, suggesting a plausible threshold of LDHC expression to elicit immune reactivity. The gene discussed is LDHC; the disease is cancer.